Author

Emily R. Mason

Indiana University Indianapolis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Approach:experimental assay· 1

Frequent Co-Authors

Disha M. Soni· 3 shared Shaoyou Chu· 3 shared Timothy I. RichardsoniD· 3 shared Adrian L. OblakiD· 2 shared Adam K. HamdaniiD· 1 shared Alan David Palkowitz· 1 shared Alexandra N. Faulkner· 1 shared Alison Donnelly AxtmaniD· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersNeuroscience

Disha M. Soni

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pharmacology & ToxicologyJournal of Medicinal ChemistryPeer-reviewedApr 30, 2026

Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease Models

Cynthia D. Jesudason, Claudia Rangel‐Barajas, Colin J Beach…·Timothy I. Richardson

This study identifies SHIP1 ligands with brain exposure and in vivo activity in Alzheimer's models, showing target engagement and reduced neuroinflammation.

1 citation

mouseproteomics

𝕏 PostBluesky

NeuroscienceJournal of ProteomicsPeer-reviewedMay 20, 2024

SHIP1 modulation and proteome characterization of microglia

Erpan Ahat, Zanyu Shi, Shaoyou Chu…·Timothy I. Richardson

This study examines the proteomic and transcriptomic effects of SHIP1 modulation in microglia, revealing significant proteomic changes in SHIP1 homozygous knockout and differences between BV2 and HMC3 cell lines.

3 citations

mouseproteomics

𝕏 PostBluesky

NeuroscienceAlzheimer s & Dementia Translational Research & Clinical InterventionsPeer-reviewedJan 1, 2022

AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discovery

Frances Potjewyd, Joel K. Annor‐Gyamfi, Jeffrey Aubé…·Alison Donnelly Axtman

The paper compiles an annotated set of 171 small molecule modulators targeting 98 novel AD therapeutic proteins, serving as chemical tools for hypothesis validation.

6 citations

statistical modeldrug response / drug discovery

𝕏 PostBluesky